The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHZD.L Regulatory News (HZD)

  • There is currently no data for HZD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 2.9 Announcement

11 Nov 2020 11:28

RNS Number : 9930E
Horizon Discovery Group plc
11 November 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

For immediate release

11 November 2020

Horizon Discovery Group plc 

("Horizon" or the "Company")

Rule 2.9 Announcement

 

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, Horizon confirms that, on 11 November 2020 (the date of this announcement), it has 158,237,652 ordinary shares of £0.01 each in issue and admitted to trading on AIM. The International Securities Identification Number ("ISIN") for the Company's ordinary shares is GB00BK8FL363.

Enquiries:

Horizon

Terry Pizzie, Chief Executive Officer Tel: +44 (0) 12 2365 5580 Jayesh Pankhania, Chief Financial Officer

Jon Davies, Head of Investor Relations

Evercore (Lead Financial Adviser to Horizon)

Simon Elliott Tel: +44 (0) 20 7653 6000

Edward Banks

Numis (Joint Financial Adviser, Broker and NOMAD to Horizon)

Freddie Barnfield Tel: +44 (0) 20 7260 1000

Stuart Ord Duncan Monteith

Consilium Strategic Communications (Financial Media and UK Investor Relations Adviser to Horizon)

Mary-Jane Elliott Tel: +44 (0) 7720 088 468

Matthew Neal Melissa Gardiner

 

Disclaimer

Evercore Partners International LLP ("Evercore"), which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively as financial adviser to Horizon and no one else in connection with the matters described in this Announcement and will not be responsible to anyone other than Horizon for providing the protections afforded to clients of Evercore nor for providing advice in connection with the matters referred to herein. Neither Evercore nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, in delict, under statute or otherwise) to any person who is not a client of Evercore in connection with this Announcement, any statement contained herein, any offer or otherwise. Apart from the responsibilities and liabilities, if any, which may be imposed on Evercore by the Financial Services and Markets Act 2000, or the regulatory regime established thereunder, or under the regulatory regime of any jurisdiction where exclusion of liability under the relevant regulatory regime would be illegal, void or unenforceable, neither Evercore nor any of its affiliates accepts any responsibility or liability whatsoever for the contents of this Announcement, and no representation, express or implied, is made by it, or purported to be made on its behalf, in relation to the contents of this Announcement, including its accuracy, completeness or verification of any other statement made or purported to be made by it, or on its behalf, in connection with Horizon or the matters described in this document. To the fullest extent permitted by applicable law, Evercore and its affiliates accordingly disclaim all and any responsibility or liability whether arising in tort, in delict, contract or otherwise (save as referred to above) which they might otherwise have in respect of this Announcement or any statement contained herein.

Numis Securities Limited ("Numis"), which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for Horizon and no one else in connection with the matters set out in this Announcement and will not regard any other person as its client in relation to the matters in this Announcement and will not be responsible to anyone other than Horizon for providing the protections afforded to clients of Numis, nor for providing advice in relation to any matter referred to herein.

 

Publication on website

In accordance with Rule 26.1 of the Code, a copy of this announcement will be made available (subject to certain restrictions relating to persons resident in restricted jurisdictions), free of charge, on the Company's website at www.horizondiscoveryplc.com by no later than 12:00 noon on the business day following the date of this announcement. Neither the content of this website nor the content of any other website accessible from hyperlinks on such website is incorporated into, or forms part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTTUAUARRBUAAAA
Date   Source Headline
26th Jan 20187:00 amRNSBlock Listing Six Monthly Return
18th Dec 20177:00 amRNSAgreement with Roche Diagnostics
5th Dec 20177:00 amRNSHZD expand CRISPR license rights with ERS Genomics
24th Nov 20172:54 pmRNSTotal Voting Rights
3rd Oct 20172:10 pmRNSTotal Voting Rights
26th Sep 20177:00 amRNSInterim Results
25th Sep 20173:35 pmRNSHoldings in Company
8th Sep 20177:00 amRNSTrading Update
4th Sep 20173:42 pmRNSHolding(s) in Company
4th Sep 20172:37 pmRNSHolding(s) in Company
31st Aug 20173:30 pmRNSCompletion of Acquisition
24th Aug 20173:56 pmRNSHolding(s) in Company
24th Aug 20173:29 pmRNSHolding(s) in Company
23rd Aug 20178:18 amRNSCompletion of Placing
22nd Aug 20172:12 pmRNSUpdate on Acquisition of GE Healthcare Dharmacon
7th Aug 201710:19 amRNSResult of General Meeting
7th Aug 20177:00 amRNSDirector/PDMR Shareholding
24th Jul 20177:00 amRNSBlock Listing Application
19th Jul 20177:00 amRNSAcquisition and Proposed Placing to Raise £80m
7th Jul 20177:00 amRNSAdditional Listing
4th Jul 20171:55 pmRNSHoldings in Company
3rd Jul 20177:00 amRNSReference Standards support successful FDA filing
28th Jun 201710:57 amRNSResult of AGM
26th Jun 20171:54 pmRNSHolding(s) in Company
16th Jun 20177:00 amRNSAdditional Listing
6th Jun 20177:00 amRNSAdditional Listing
2nd Jun 20177:00 amRNSAnnual Report and Notice of Annual General Meeting
31st May 20177:00 amRNSAdditional Listing
30th May 20177:00 amRNSPreliminary Results Year Ended 31 December 2016
22nd May 20177:00 amRNSHZD Licenses New Gene Editing Technology Platform
9th May 20177:00 amRNSPerformance update in Immuno-Oncology
21st Apr 20177:00 amRNSAdditional Listing
19th Apr 20177:00 amRNSNotice of Results
11th Apr 20172:57 pmRNSHoldings in Company
7th Apr 20175:01 pmRNSGrant of Options
6th Apr 20177:00 amRNSAdditional Listing
30th Mar 20179:08 amRNSHoldings in Company
24th Mar 20177:00 amRNSAdditional Listing
23rd Mar 201711:24 amRNSHoldings in Company
20th Mar 201710:42 amRNSHoldings in Company
14th Mar 20177:00 amRNSAgreement for NIPT Reference Standards
23rd Feb 20177:00 amRNSSite Visit
20th Feb 20171:21 pmRNSHolding(s) in Company
15th Feb 20177:00 amRNSAdditional Listing
14th Feb 20177:00 amRNSMaster Service Agreement with Top 3 Pharma Company
10th Feb 20177:00 amRNSAdditional Listing
31st Jan 20173:06 pmRNSHolding(s) in Company
31st Jan 20177:00 amRNSIssue of Equity
26th Jan 20171:50 pmRNSHolding(s) in Company
24th Jan 20177:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.